Valgenesis VLMS 4.1 SP1 PS7

Paperless validation tool

Published by: ValGenesis
Downloads
Revenue

Description

ValGenesis, Inc. is the provider of the first enterprise application that manages the corporate validation lifecycle process. This solution is fully compliant with U.S. FDA 21 CFR Part 11 and Annex 11 requirements. As the first fully paperless solution for electronic management of validation execution and approval, ValGenesis was selected by an industry peer review committee to receive the Parenteral Drug Association (PDA) New Innovative Technology Award in 2005
Hide Show More...

Screenshots

Valgenesis VLMS 4.1 SP1 PS7 FAQ

  • Is Valgenesis VLMS 4.1 SP1 PS7 free?

    Yes, Valgenesis VLMS 4.1 SP1 PS7 is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is Valgenesis VLMS 4.1 SP1 PS7 legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does Valgenesis VLMS 4.1 SP1 PS7 cost?

    Valgenesis VLMS 4.1 SP1 PS7 is free.

  • What is Valgenesis VLMS 4.1 SP1 PS7 revenue?

    To get estimated revenue of Valgenesis VLMS 4.1 SP1 PS7 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in South Korea yet.
Ratings History

Valgenesis VLMS 4.1 SP1 PS7 Reviews

No Reviews in South Korea
App doesn't have any reviews in South Korea yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

Valgenesis VLMS 4.1 SP1 PS7 Installs

Last 30 days

Valgenesis VLMS 4.1 SP1 PS7 Revenue

Last 30 days

Valgenesis VLMS 4.1 SP1 PS7 Revenue and Downloads

Gain valuable insights into Valgenesis VLMS 4.1 SP1 PS7 performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Category
Medical
Publisher
ValGenesis
Languages
English
Recent release
4.1 (2 years ago )
Released on
Jun 12, 2022 (2 years ago )
Last Updated
1 month ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.